SWK Holdings Corporation
Dallas, Texasswkhold.com
Overview
SWKH, a life science-focused specialty finance company, provides flexible financing solutions and partners with small- and mid-sized commercial-stage healthcare companies. SWK's solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases typically ranging in size from $5.0 million to $25.0 million. SWK also owns MOD3 Pharma, a clinical development and manufacturing organization providing development services to pharmaceutical partners.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| NeoLight | Feb 2023 | Debt | Lead |
| MedMinder Systems | Aug 2022 | Early Funding | - |
| MolecuLight Inc. | Jan 2022 | Debt | Lead |
| 4WEB Medical | May 2021 | Debt | Lead |
| Flowonix | Jan 2021 | Debt | - |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
